prof. dr. Pieter Depuydt
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent - Pieter.Depuydt@UGent.be
Show
Sort by
-
- Journal Article
- A1
- open access
Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge
-
Healthcare-associated infections in adult intensive care unit patients : changes in epidemiology, diagnosis, prevention and contributions of new technologies
-
Antimicrobial prescription in severe COVID-19 and CAP : a matched case-control study
-
Foxglove poisoning : diagnostic and therapeutic differences with medicinal digitalis glycosides overdose
-
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial
-
- Journal Article
- A1
- open access
Characteristics of Sepsis-2 septic shock patients failing to satisfy the Sepsis-3 septic shock definition : an analysis of real-time collected data
-
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial
-
- Journal Article
- A1
- open access
Outcomes of ICU patients with and without perceptions of excessive care : a comparison between cancer and non-cancer patients
-
- Journal Article
- A1
- open access
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
-
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU) : a randomised, open-label, proof-of-concept trial